Correlation Between 23Andme Holding and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Travere Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Travere Therapeutics.
Diversification Opportunities for 23Andme Holding and Travere Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between 23Andme and Travere is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Travere Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Travere Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Travere Therapeutics. In addition to that, 23Andme Holding is 2.4 times more volatile than Travere Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 1,750 in Travere Therapeutics on September 1, 2024 and sell it today you would earn a total of 131.00 from holding Travere Therapeutics or generate 7.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Travere Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Travere Therapeutics |
23Andme Holding and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Travere Therapeutics
The main advantage of trading using opposite 23Andme Holding and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |